Pharmacoepidemiology And Pharmacovigilance at Meripustak

Pharmacoepidemiology And Pharmacovigilance

Books from same Author: Sabrina Nour

Books from same Publisher: Academic Press

Related Category: Author List / Publisher List


  • Retail Price: ₹ 13290/- [ 5.00% off ]

    Seller Price: ₹ 12626

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Sabrina Nour
    PublisherAcademic Press
    Edition1st Edition
    ISBN9780128161838
    Pages144
    LanguageEnglish
    Publish YearJanuary 2019

    Description

    Academic Press Pharmacoepidemiology And Pharmacovigilance by Sabrina Nour

    Pharmacoepidemiology and Pharmacovigilance: Synergistic Tools to Better Investigate Drug Safety examines the role of pharmacoepidemiologic studies in drug development and its use as a prevention tool in pharmacovigilance activities. The book introduces the various epidemiologic tools and study designs commonly used for the surveillance of drug-related adverse effects and reviews the strengths and weaknesses of each. Criticisms surrounding pharmacoepidemiologic research and issues that often interfere or complicate the conduct and interpretation of these studies are also explored. Case studies illustrate the passive and active surveillance of adverse drug reactions in clinical situations, covering important pharmacoepidemiologic concepts like health risk management and safety. The book helps pharmaceutical industry groups engaged in drug safety, clinical investigators, medical evaluators and those seeking regulatory approval enhance the safety of the drug development process for all patient populations.